Bioventus's total assets for Q2 2025 were $706.79M, an increase of 2.22% from the previous quarter. BVS total liabilities were $505.49M for the fiscal quarter, a -0.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.